ALC 1.85% 5.5¢ alcidion group limited

General Discussion / Social Media, page-28

  1. 1,000 Posts.
    lightbulb Created with Sketch. 385
    Kate Quirke @ 121 investment conference Hong Kong 13-14 June 2018

    https://www.weare121.com/121techinvestment-hk/alcidion/

    Kate Quirke, CEO
    Kate is a highly experienced executive with a deep expertise in the healthcare IT sector. Kate was previously the CEO of MKM Health for the past two years, and prior to this role she was the Head of Sales and Marketing at MKM Health. Since initially joining MKM Health as Sales Director in FY2012, Kate has increased MKM Health revenues by over 2.5 times, achieving a compound average annual growth rate of 29%.

    What is your rationale for attending 121 Tech Investment?
    Alcidion is looking for strategic and financial investors who share in its vision and long-term growth strategy; seek new international market opportunities across Singapore, Hong Kong and Malaysia

    What recent news would you like to highlight to investors attending?
    Transformative acquisition of health informatics software and services company MKM health in Australia and New Zealand, and Patientrack in the UK.
    The transformative Acquisition creates a new and leading specialist health IT solution provider focused on “next generation” decision intelligence technology designed for hospital and allied healthcare customers globally. Patientrack and Alcidion’s existing Miya and Smartpage product sets will provide the expanded group with a strong foundation of complementary technologies.

    What are your key goals for the next 3, 6 and 12 months?3 MONTH GOALSIntegrate key MKM Health sales & marketing personnel

    Leverage domestic MKM Health relationships

    6 MONTH GOALSLaunch integrated Patientrack and Miya PatientFlow product offering

    New analytics & advanced metrics products to be launched in 2018

    Further investment in UK sales and marketing team

    12 MONTH GOALSExploring additional point-of-care product offering

    Cross-selling of Miya products into UK market

    What do you see as the key risks and challenges facing your company at the moment and how are you overcoming these?

    In a sentence, what do you think makes your company such a compelling investment?

    Alicidion offers leading healthcare system integration, implementation and software support capabilities, required by both individual healthcare providers and state health agencies to build integrated health informatics platforms, a necessary basis in order to deliver truly integrated healthcare.
    Last edited by Up2Date: 22/06/18
 
watchlist Created with Sketch. Add ALC (ASX) to my watchlist
(20min delay)
Last
5.5¢
Change
0.001(1.85%)
Mkt cap ! $73.83M
Open High Low Value Volume
5.5¢ 5.9¢ 5.3¢ $168.1K 2.998M

Buyers (Bids)

No. Vol. Price($)
1 100000 5.3¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 78405 3
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
5.3¢
  Change
0.001 ( 1.15 %)
Open High Low Volume
5.6¢ 5.9¢ 5.3¢ 1081166
Last updated 15.59pm 26/04/2024 ?
ALC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.